United States
Germany
Japan
United Kingdom
China
Neurexin II alpha (NRXN2) (NM_015080) Human Untagged Clone
CAT＃: SC319037
NRXN2 (untagged)-Human neurexin 2 (NRXN2), transcript variant alpha-1
CNY 32,870.00
货期*
4周
规格
Product images
经常一起买 (3)
Specifications
| Product Data | |
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
| E. coli Selection | Kanamycin (25 ug/mL) |
| Mammalian Cell Selection | Neomycin |
| Sequence Data |
>SC319037 representing NM_015080.
Blue=Insert sequence Red=Cloning site Green=Tag(s) GCTCGTTTAGTGAACCGTCAGAATTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTG GATCCGGTACCGAGGAGATCTGCCGCCGCGATCGCC ATGGCGTCCGGGAGCCGGTGGCGGCCGACACCGCCGCCGCTGCTGTTGCTGCTGCTGCTGGCGCTGGCG GCGCGCGCGGACGGCCTGGAGTTCGGCGGCGGCCCCGGGCAGTGGGCTCGCTACGCGCGCTGGGCGGGC GCGGCGAGCAGCGGCGAGCTCAGCTTCAGCCTGCGCACCAACGCCACGCGCGCGCTGCTGCTCTACCTG GACGACGGCGGCGACTGCGACTTCCTGGAGCTGCTGCTGGTGGACGGCCGCCTGCGGCTGCGCTTCACG CTTTCGTGCGCCGAGCCGGCCACGCTGCAGCTGGACACGCCGGTGGCCGACGACCGCTGGCACATGGTG CTGCTGACCCGCGACGCGCGCCGCACGGCGCTGGCGGTGGACGGCGAGGCCCGCGCCGCCGAGGTGCGC TCCAAGCGGCGCGAGATGCAGGTGGCCAGCGACCTGTTCGTGGGCGGCATCCCGCCCGACGTGCGCCTC TCGGCGCTTACGCTGAGCACCGTCAAGTACGAGCCGCCCTTCCGCGGCCTCTTGGCCAACCTGAAGCTG GGCGAGCGGCCCCCCGCGCTGCTGGGCAGCCAGGGCCTGCGCGGCGCCACCGCCGACCCGCTGTGCGCG CCCGCGCGCAACCCCTGCGCCAACGGCGGCCTCTGCACCGTGCTGGCCCCCGGCGAGGTGGGCTGCGAC TGCAGCCACACGGGCTTCGGCGGCAAGTTCTGCAGCGAAGAGGAGCACCCCATGGAAGGTCCGGCTCAC CTGACGTTAAACAGCGAAGTAGGGTCCTTACTGTTCTCCGAGGGGGGGGCCGGGAGAGGAGGAGCCGGC GATGTGCACCAGCCAACAAAAGGCAAGGAGGAGTTTGTGGCGACCTTCAAAGGCAATGAGTTCTTCTGC TACGACCTGTCACACAACCCCATCCAGAGCAGCACTGATGAGATCACACTGGCCTTCCGCACCCTGCAA CGCAACGGCCTGATGCTGCATACAGGCAAGTCGGCCGACTACGTCAACCTGTCCCTCAAGTCTGGGGCT GTCTGGCTGGTCATCAACCTAGGCTCAGGTGCCTTCGAGGCCCTTGTGGAACCCGTCAATGGCAAGTTC AACGACAACGCCTGGCACGACGTCCGGGTCACCCGAAACCTGCGCCAGCACGCAGGGATTGGACACGCT ATGGTAAACAAACTGCATTATCTGGTGACCATCTCGGTGGACGGGATCCTGACCACCACAGGCTACACG CAGGAGGATTACACCATGCTGGGCTCTGATGACTTCTTCTACATTGGGGGCAGCCCCAACACAGCTGAC CTGCCGGGCTCGCCCGTCAGCAACAACTTCATGGGCTGCCTCAAGGACGTGGTCTATAAGAACAATGAC TTCAAATTGGAACTATCCCGCCTGGCAAAGGAAGGGGACCCCAAGATGAAGCTGCAGGGGGACTTGTCA TTCCGCTGTGAGGATGTGGCTGCCCTGGACCCTGTGACCTTTGAGAGTCCCGAGGCCTTTGTGGCGCTG CCCCGCTGGAGCGCTAAGCGCACTGGCTCCATCTCCCTAGACTTCCGCACCACCGAGCCCAATGGGCTG CTGCTCTTCAGCCAGGGCCGGCGGGCTGGGGGTGGAGCTGGCAGCCACAGCTCTGCTCAGCGGGCCGAC TACTTTGCCATGGAGCTATTGGACGGCCACCTCTATCTTCTGCTGGACATGGGATCTGGGGGCATCAAG CTGCGGGCATCCAGCCGCAAGGTCAATGATGGCGAGTGGTGTCACGTGGACTTCCAGAGGGATGGGCGA AAAGGCTCCATCTCAGTGAATAGTCGCAGCACGCCGTTCTTGGCCACTGGAGACAGCGAGATTCTGGAC CTGGAGAGTGAGCTGTACCTGGGCGGTCTCCCTGAGGGGGGCCGGGTGGACCTGCCCCTGCCCCCAGAG GTGTGGACAGCAGCACTCCGGGCAGGCTACGTGGGCTGTGTGCGGGACCTCTTCATAGATGGGCGTAGC CGAGACCTCCGGGGCCTGGCTGAGGCTCAGGGGGCTGTGGGCGTTGCCCCCTTTTGCTCCCGGGAGACG CTGAAGCAGTGTGCATCTGCCCCCTGTCGCAATGGGGGCGTCTGTCGAGAAGGCTGGAACCGCTTCATC TGTGACTGCATCGGGACCGGCTTTCTTGGGCGGGTCTGTGAGAGAGAGGCCACGGTCCTGAGCTACGAT GGCTCCATGTACATGAAGATCATGCTGCCTAACGCCATGCACACGGAGGCAGAGGATGTGTCCCTGCGT TTCATGTCCCAGCGGGCCTACGGACTCATGATGGCCACCACTTCCAGGGAGTCTGCCGACACCCTACGC CTGGAGCTGGATGGGGGGCAGATGAAGCTCACTGTCAACCTCGACTGCCTGCGCGTCGGCTGCGCACCC AGTAAAGGCCCCGAAACGCTGTTTGCGGGGCACAAGCTCAATGACAATGAGTGGCACACGGTGAGGGTG GTCCGGCGTGGCAAGAGCCTGCAGCTGTCTGTGGACAACGTGACTGTGGAGGGACAGATGGCAGGAGCC CATATGCGGCTGGAGTTCCACAACATTGAGACGGGCATCATGACGGAGCGGCGGTTTATCTCCGTGGTG CCCTCCAACTTCATCGGGCATCTGAGTGGGCTCGTGTTCAATGGCCAGCCCTACATGGACCAGTGCAAG GATGGTGACATCACCTACTGTGAGCTCAATGCTCGCTTTGGCCTGCGTGCCATCGTGGCCGATCCCGTC ACCTTCAAGAGTCGCAGCAGCTACCTGGCACTCGCCACGCTCCAAGCCTATGCTTCCATGCACCTCTTC TTCCAGTTCAAGACCACGGCCCCTGATGGGCTTCTTCTGTTCAACTCGGGCAACGGCAATGACTTCATT GTCATCGAGCTGGTCAAGGGGTACATCCACTACGTGTTTGACCTGGGGAATGGCCCGTCCTTGATGAAG GGGAACTCAGACAAACCAGTCAATGACAACCAGTGGCACAACGTGGTGGTGTCCAGGGACCCAGGCAAC GTGCACACGCTCAAGATTGACTCCCGCACTGTCACGCAGCACTCCAATGGCGCCCGAAACCTCGATCTC AAAGGGGAGTTGTACATTGGCGGTCTGAGCAAGAATATGTTCAGCAACCTGCCCAAGCTGGTGGCCTCC CGGGATGGCTTTCAGGGCTGCCTGGCCTCAGTGGACCTCAACGGACGTCTCCCAGACCTCATCGCCGAC GCCCTGCACCGCATTGGGCAGGTGGAGAGGGGCTGTGATGGCCCCAGCACCACCTGCACTGAAGAGTCC TGTGCCAACCAGGGCGTCTGCTTGCAGCAGTGGGATGGCTTCACCTGCGACTGCACCATGACTTCCTAT GGAGGCCCTGTCTGCAATGATCCCGGGACCACATACATCTTTGGGAAGGGGGGAGCGCTCATCACCTAC ACGTGGCCCCCCAATGACAGGCCCAGCACGAGGATGGATCGCCTGGCCGTGGGCTTCAGCACCCACCAG CGGAGCGCTGTGCTGGTGCGGGTGGACAGCGCCTCCGGCCTTGGAGACTACCTGCAGCTGCACATCGAC CAGGGCACCGTGGGGGTGATCTTTAACGTGGGCACGGACGACATTACCATCGACGAGCCCAACGCCATA GTAAGCGACGGCAAATACCACGTGGTGCGCTTCACTCGAAGCGGCGGCAACGCCACCCTGCAGGTGGAC AGCTGGCCGGTCAACGAGCGGTACCCGGCAGGAAACTTTGATAACGAGCGCCTGGCGATTGCTAGACAG AGAATCCCCTACCGGCTTGGTCGAGTAGTAGATGAGTGGCTGCTCGACAAAGGCCGCCAGCTGACCATC TTCAACAGCCAGGCTGCCATCAAGATCGGGGGCCGGGATCAGGGCCGCCCCTTCCAGGGCCAGGTGTCC GGCCTCTACTACAATGGGCTCAAGGTGCTGGCGCTGGCCGCCGAGAGCGACCCCAATGTGCGGACTGAG GGTCACCTGCGCCTGGTGGGGGAGGGGCCGTCCGTGCTGCTCAGTGCGGAGACCACGGCCACCACCCTG CTGGCTGACATGGCCACCACCATCATGGAGACTACCACCACCATGGCCACTACCACCACGCGCCGGGGC CGCTCCCCCACACTGAGGGACAGCACCACCCAGAACACAGATGACCTGCTGGTGGCCTCTGCTGAGTGT CCAAGCGATGATGAGGACCTGGAGGAGTGTGAGCCCAGTACTGGAGGAGAGTTAATATTGCCCATTATC ACGGAGGACTCCTTAGACCCCCCTCCCGTGGCCACCCGATCCCCCTTCGTGCCCCCGCCCCCTACCTTC TACCCCTTCCTCACGGGAGTGGGCGCCACCCAAGACACGCTGCCCCCGCCCGCCGCGCGCCGCCCGCCC TCTGGGGGCCCGTGCCAGGCCGAGCGGGACGACAGCGACTGCGAGGAGCCCATCGAGGCCTCGGGCTTC GCCTCCGGGGAGGTCTTTGACTCCAGCCTCCCCCCCACGGACGACGAGGACTTTTACACCACCTTTCCC CTGGTCACGGACCGCACCACCCTCCTGTCACCCCGCAAACCCGCTCCCCGGCCCAACCTCAGGACAGAT GGGGCCACGGGCGCCCCTGGGGTGCTGTTTGCCCCCTCCGCCCCGGCCCCCAACCTGCCGGCGGGCAAA ATGAACCACCGAGACCCGCTTCAGCCCTTGCTGGAGAACCCGCCCTTGGGGCCCGGGGCCCCCACGTCC TTTGAGCCGCGGAGGCCCCCTCCCCTGCGCCCCGGCGTGACCTCAGCCCCCGGCTTCCCCCATCTGCCC ACAGCCAACCCCACAGGGCCTGGGGAGCGGGGCCCGCCGGGCGCAGTGGAGGTGATCCGGGAGTCCAGC AGCACCACGGGCATGGTGGTGGGCATTGTGGCGGCGGCGGCGCTCTGCATCCTCATCCTCCTCTACGCC ATGTATAAGTACCGCAATCGTGATGAGGGCTCCTACCAGGTGGACCAGAGCCGAAACTACATCAGTAAC TCGGCCCAGAGCAATGGGGCGGTGGTGAAAGAGAAGGCCCCGGCTGCCCCCAAGACGCCCAGCAAGGCC AAGAAGAACAAAGACAAGGAGTATTATGTCTGA ACGCGTACGCGGCCGCTCGAGCAGAAACTCATCTCAGAAGAGGATCTGGCAGCAAATGATATCCTGGAT TACAAGGATGACGACGATAAGGTTTAAACGGCCGGC |
| Restriction Sites | SgfI-MluI |
| ACCN | NM_015080 |
| Insert Size | 5139 bp |
| OTI Disclaimer | Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP). |
| OTI Annotation | This TrueClone is provided through our Custom Cloning Process that includes sub-cloning into OriGene's pCMV6 vector and full sequencing to provide a non-variant match to the expected reference without frameshifts, and is delivered as lyophilized plasmid DNA. |
| Product Components | The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water). |
| Reconstitution | 1. Centrifuge at 5,000xg for 5min. 2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA. 3. Close the tube and incubate for 10 minutes at room temperature. 4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom. 5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C. |
| Reference Data | |
| RefSeq | NM_015080.3 |
| RefSeq Size | 6639 bp |
| RefSeq ORF | 5139 bp |
| Locus ID | 9379 |
| UniProt ID | Q9P2S2 |
| Protein Families | Druggable Genome, Transmembrane |
| Protein Pathways | Cell adhesion molecules (CAMs) |
| MW | 185 kDa |
| Gene Summary | This gene encodes a member of the neurexin gene family. The products of these genes function as cell adhesion molecules and receptors in the vertebrate nervous system. These genes utilize two promoters. The majority of transcripts are produced from the upstream promoter and encode alpha-neurexin isoforms while a smaller number of transcripts are produced from the downstream promoter and encode beta-neuresin isoforms. The alpha-neurexins contain epidermal growth factor-like (EGF-like) sequences and laminin G domains, and have been shown to interact with neurexophilins. The beta-neurexins lack EGF-like sequences and contain fewer laminin G domains than alpha-neurexins. Alternative splicing and the use of alternative promoters may generate thousands of transcript variants (PMID: 12036300, PMID: 11944992).[provided by RefSeq, Jun 2010] Transcript Variant: This variant (alpha-1) encodes the longest isoform (alpha-1). Sequence Note: This RefSeq record was created from transcript and genomic sequence data to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on transcript alignments. |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
Other Versions
| SKU | Description | Size | Price |
|---|---|---|---|
| RC219788 | NRXN2 (Myc-DDK-tagged)-Human neurexin 2 (NRXN2), transcript variant alpha-1 |
CNY 11,512.00 |
|
| RC219788L1 | Lenti ORF clone of Human neurexin 2 (NRXN2), transcript variant alpha-1, Myc-DDK-tagged |
CNY 13,912.00 |
|
| RC219788L3 | Lenti ORF clone of Human neurexin 2 (NRXN2), transcript variant alpha-1, Myc-DDK-tagged |
CNY 19,000.00 |
|
| RG219788 | NRXN2 (tGFP-tagged) - Human neurexin 2 (NRXN2), transcript variant alpha-1 |
CNY 18,810.00 |
其它Neurexin II alpha产品
Customer
Reviews
Loading...
